Hospital de la Santa Creu i Sant Pau

Hospital


Location: Barcelona, Spain (ES) ES

ISNI: 0000000417688905

ROR: https://ror.org/059n1d175

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells (2024) Staniek J, Kalina T, Andrieux G, Boerries M, Janowska I, Fuentes M, Díez P, et al. Journal article EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis (2023) Zabotti A, De Marco G, Gossec L, Baraliakos X, Aletaha D, Iagnocco A, Gisondi P, et al. Journal article Immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients receiving secukinumab: a literature review (2023) Gisondi P, Simon D, Alarcon I, Pournara E, Puig L Journal article, Review article Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort (2022) Kuster S, Jordan S, Elhai M, Held U, Steigmiller K, Bruni C, Cacciapaglia F, et al. Journal article Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database (2022) Iudici M, Mongin D, Siegert E, Carreira PE, Distler J, Henes J, Zanatta E, et al. Journal article A randomized phase II trial of ipilimumab and nivolumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNNIFORECAST) (2022) Ahrens M, Escudier B, Haanen J, Gross-Goupil M, Boleti E, Gravis G, Grimm MO, et al. Conference contribution GLUCOCORTICOIDS PRESCRIBING PRACTICES IN SYSTEMIC SCLEROSIS: AN ANALYSIS OF THE EUSTAR DATABASE. (2022) Iudici M, Mongin D, Siegert E, Carreira P, Distler J, Henes J, Zanatta E, et al. Conference contribution Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment (2022) Reinoso-Segura M, Caballero-Velazquez T, Herrera P, Patriarca F, Fanin R, Bruno B, Einsele H, et al. Journal article The global pandemic and changes in women's reproductive health: an observational study (2022) Haile L, Van De Roemer N, Gemzell-Danielsson K, Perello Capo J, Lete Lasa I, Vannuccini S, Koch MC, et al. Journal article The 3rd ESTRO-EFOMP core curriculum for medical physics experts in radiotherapy (2022) Garibaldi C, Essers M, Heijmen B, Bertholet J, Koutsouveli E, Schwarz M, Bert C, et al. Journal article